[Focus] Two drugs converged in a pancreatic {beta} cell

Combining a DYRK1A inhibitor and GLP-1 receptor agonist boosts human pancreatic β cell proliferation and glucose homeostasis in vivo (Ackeifi et al., this issue).

Source: Science Translational Medicine - February 11, 2020 Category: Biomedical Science Authors: Scavuzzo, M. A., Borowiak, M. Tags: Focus Source Type: research